Novartis Australia Pty Limited is a limited by shares, Australian proprietary company. This corporation was registered on 1957-01-24 and was issued with the 004371224 ACN. Its Australian Business Number is 81004371224. Since 2008-04-30, the company is headquartered in NSW, post code 2113. The previous headquarters were located in NSW 2125 (from 2007-10-01 to 2008-04-30), NSW 2145 (from 2000-07-16 to 2007-10-01). Novartis Australia Pty Limited was registered for the GST on 2000-07-01. Novartis Australia Pty Limited has been using the Novartis Australia Pty Ltd trading name since 2000-07-16 (it needs to be noted that the Australian Business Register no longer collects or updates trading names). In total the company used 1 trading name. The above data comes from the ABN database which was updated on 2012-10-05.
| Status | From | To |
|---|---|---|
| Active | Sat, 1st Apr 2000 | current |
| Name | From | To |
|---|---|---|
| Novartis Australia Pty Limited | Thu, 5th Oct 2000 | current |
| Novartis Australia P/l | Sat, 1st Apr 2000 | Thu, 5th Oct 2000 |
| Name | From | To |
|---|---|---|
| Novartis Australia Pty Ltd | Sun, 16th Jul 2000 | current |
| Location | From | To |
|---|---|---|
| NSW 2113 | Wed, 30th Apr 2008 | current |
| NSW 2125 | Mon, 1st Oct 2007 | Wed, 30th Apr 2008 |
| NSW 2145 | Sun, 16th Jul 2000 | Mon, 1st Oct 2007 |
| Status | From | To |
|---|---|---|
| Registered | Sat, 1st Jul 2000 | current |
Advertisements
Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.